Marinomed Biotechnologie has signed a licensing agreement with Boehringer Ingelheim to market Marinomed’s anti-viral nasal spray for treating the common cold in Europe (except Austria and UK), Russia and CIS, South America, parts of Asia, and Australia.
29 June, 2010
Researchers have been awarded £1.8 million to examine whether the use of pesticides is hampering the cognitive functions of bees – and possibly hastening their demise.
22 June, 2010
Clinical results from a Phase IIb study have shown that MK-4305, Merck's investigational dual orexin receptor antagonist, was significantly more effective than placebo in improving overall sleep efficiency in patients with primary insomnia.
18 June, 2010